A Study of Exclusion Criteria in a University Population
NCT ID: NCT01472536
Last Updated: 2016-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1400 participants
INTERVENTIONAL
2011-11-30
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators are conducting a study on the effect of voluntary sequestration during illness on the transmission of influenza among social networks in University residence housing units at the University of Michigan. The sequestration interventions will be carried out during a period of influenza transmission that is defined by surveillance conducted at the University Health Service. Data will be collected on use of the interventions and the occurrence of influenza and other illnesses. In all selected residence halls, specimens will be collected when illness meeting a case definition for influenza-like illness occurs.
This study in a university population will evaluate the acceptability and magnitude of effect that can be expected from such an intervention, and determine the number of days that sequestration should be practiced.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission
NCT00490633
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556
Evaluating Modes of Influenza Transmission Between Humans
NCT01150149
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
NCT01769430
Collaborative Efforts to Increase Flu Vaccination
NCT01403649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3-day sequestration
Students will be sequestered within their residence hall room for 3 days following influenza like illness symptoms
Sequestration
Students will be sequestered within their residence hall room for 3 days following influenza like illness symptoms.
Control
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sequestration
Students will be sequestered within their residence hall room for 3 days following influenza like illness symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years of age
* Be willing to report social habits and illness information electronically on a weekly basis
* Be willing to have a throat swab specimen collected if you have signs of illness during the influenza season
* Be willing to nominate close social contacts living in eligible residence halls for participation in the study
* Be willing to participate in a 3-day sequestration protocol as randomly assigned.
Exclusion Criteria
* Unwillingness to participate in voluntary sequestration protocol and complete online surveys
* Already study employee
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Allison Aiello
Associate Professor, Epidemiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Allison E Aiello, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Arnold S Monto, MD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.